» Articles » PMID: 32862049

Molecular Mechanisms Employed by Enteric Bacterial Pathogens to Antagonise Host Innate Immunity

Overview
Specialty Microbiology
Date 2020 Aug 31
PMID 32862049
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Many Gram-negative enteric pathogens, including enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC), Salmonella, Shigella, and Yersinia species have evolved strategies to combat host defence mechanisms. Critical bacterial virulence factors, which often include but are not limited to type III secreted effector proteins, are deployed to cooperatively interfere with key host defence pathways. Recent studies in this area have not only contributed to our knowledge of bacterial pathogenesis, but have also shed light on the host pathways that are critical for controlling bacterial infection. In this review, we summarise recent breakthroughs in our understanding of the mechanisms utilised by enteric bacterial pathogens to rewire critical host innate immune responses, including cell death and inflammatory signaling and cell-intrinsic anti-microbial responses such as xenophagy.

Citing Articles

Context-dependent change in the fitness effect of (in)organic phosphate antiporter glpT during Salmonella Typhimurium infection.

Santamaria de Souza N, Cherrak Y, Andersen T, Vetsch M, Barthel M, Kroon S Nat Commun. 2025; 16(1):1912.

PMID: 39994176 PMC: 11850910. DOI: 10.1038/s41467-025-56851-5.


Sirtuin 1 in Host Defense during Infection.

Kim J, Silwal P, Jo E Cells. 2022; 11(18).

PMID: 36139497 PMC: 9496836. DOI: 10.3390/cells11182921.


The role of RHIM in necroptosis.

Riebeling T, Kunzendorf U, Krautwald S Biochem Soc Trans. 2022; 50(4):1197-1205.

PMID: 36040212 PMC: 9444067. DOI: 10.1042/BST20220535.


Reprogramming of Cell Death Pathways by Bacterial Effectors as a Widespread Virulence Strategy.

Wanford J, Hachani A, Odendall C Infect Immun. 2022; 90(5):e0061421.

PMID: 35467397 PMC: 9119048. DOI: 10.1128/iai.00614-21.


NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector.

Giogha C, Scott N, Wong Fok Lung T, Pollock G, Harper M, Goddard-Borger E PLoS Pathog. 2021; 17(6):e1009658.

PMID: 34133469 PMC: 8238200. DOI: 10.1371/journal.ppat.1009658.